Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2018-03-27 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于对全资子公司增资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the capital increase (增资) of a wholly-owned subsidiary by the company. It details the use of funds raised through a non-public share issuance and the company's own funds to increase the registered capital of its subsidiary. The document includes financial data of the subsidiary, approvals from the board, independent directors, and supervisory board, and compliance with regulatory requirements. It is not a full financial report, audit report, or earnings release, but rather a specific update on financing activity related to capital injection into a subsidiary. The document length is under 5,000 characters and is a formal announcement of a financing event rather than a detailed report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2018-03-27 Chinese
独立董事关于公司第三届董事会第十九次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the company's 19th board meeting of the third session, specifically regarding capital increase in a wholly-owned subsidiary. It references compliance with regulatory guidelines and company bylaws, and expresses agreement with the capital increase. The document is a formal opinion related to board meeting decisions, not a full report or financial statement. It does not contain financial data or results, nor is it a notice of voting results or a proxy statement. It fits best under Board/Management Information (MANG) as it relates to board meeting matters and management decisions.
2018-03-27 Chinese
关于终止筹划重大事项的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company SanNuo Bio-sensing Co., Ltd. regarding the termination of a major planned transaction. It details the background of the planned transaction, the reasons for termination, and the impact on the company. There are no financial statements, no detailed financial data, or comprehensive report content. The document is a regulatory announcement about a corporate event (termination of a major matter) rather than a full report or financial disclosure. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a significant corporate event that does not fit other specific categories.
2018-03-21 Chinese
关于董事、监事和高级管理人员持股情况变动报告的公告
Director's Dealing Classification · 95% confidence The document is a formal announcement from a company regarding changes in shareholdings of its directors, supervisors, and senior management. It details the shareholding numbers before and after a non-public issuance of shares, including the impact on shareholding percentages due to the increase in total shares. The document explicitly reports on the holdings of board members and senior executives, with no financial statements or earnings data. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives. The document length is short (1366 characters), and it is not an announcement of a report publication but a direct report of shareholding changes. Therefore, the appropriate classification is DIRS (Director's Dealing).
2018-03-11 Chinese
中信证券股份有限公司关于公司发行股份购买资产并募集配套资金之重大资产重组之实施情况的独立财务顾问核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion related to a major asset restructuring involving issuance of shares to purchase assets and raising supporting funds by 三诺生物传感股份有限公司. It includes extensive information on the transaction scheme, approval processes, asset transfer, share issuance, fundraising details, compliance with laws and regulations, and related commitments. The document is lengthy (15,000 characters) and contains substantive financial and transactional data, not merely an announcement or certification. It is clearly focused on the implementation and verification of a major asset restructuring transaction, which aligns with the category of Capital/Financing Update (CAP).
2018-03-11 Chinese
中信证券股份有限公司关于公司发行股份购买资产并募集配套资金之非公开发行股票发行过程和认购对象合规性的报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report by CITIC Securities Co., Ltd. acting as the independent financial advisor and lead underwriter for a non-public issuance of shares by SanNuo Biological Sensor Co., Ltd. It covers the issuance process, pricing, number of shares, subscription details, compliance with laws and regulations, approvals from regulatory bodies including the China Securities Regulatory Commission, and the final subscription and payment status. The document is a compliance and procedural report related to a capital raising transaction involving issuance of shares to specific investors. It is not an announcement of the issuance, nor a general regulatory filing or a simple notice. It is a formal report on the issuance process and compliance, which fits the category of Capital/Financing Update (CAP). The document length is over 7,000 characters and contains substantive details about the issuance process and compliance, not just a brief announcement or certification. Therefore, the appropriate classification is CAP with high confidence.
2018-03-11 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.